New Results
Predictions of immunogenicity reveal potent SARS-CoV-2 CD8+ T-cell epitopes
David Gfeller, Julien Schmidt, Giancarlo Croce, Philippe Guillaume, Sara Bobisse, Raphael Genolet, Lise Queiroz, Julien Cesbron, View ORCID ProfileJulien Racle, Alexandre Harari
doi: https://doi.org/10.1101/2022.05.23.492800
David Gfeller
1Department of Oncology, Ludwig Institute for Cancer Research Lausanne, University of Lausanne, Switzerland
2Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland
Julien Schmidt
3Department of Oncology, Ludwig Institute for Cancer Research Lausanne, University Hospital of Lausanne, Switzerland
4Center of Experimental Therapeutics, Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Giancarlo Croce
1Department of Oncology, Ludwig Institute for Cancer Research Lausanne, University of Lausanne, Switzerland
2Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland
Philippe Guillaume
3Department of Oncology, Ludwig Institute for Cancer Research Lausanne, University Hospital of Lausanne, Switzerland
4Center of Experimental Therapeutics, Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Sara Bobisse
3Department of Oncology, Ludwig Institute for Cancer Research Lausanne, University Hospital of Lausanne, Switzerland
Raphael Genolet
3Department of Oncology, Ludwig Institute for Cancer Research Lausanne, University Hospital of Lausanne, Switzerland
Lise Queiroz
3Department of Oncology, Ludwig Institute for Cancer Research Lausanne, University Hospital of Lausanne, Switzerland
Julien Cesbron
3Department of Oncology, Ludwig Institute for Cancer Research Lausanne, University Hospital of Lausanne, Switzerland
Julien Racle
1Department of Oncology, Ludwig Institute for Cancer Research Lausanne, University of Lausanne, Switzerland
2Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland
Alexandre Harari
3Department of Oncology, Ludwig Institute for Cancer Research Lausanne, University Hospital of Lausanne, Switzerland
4Center of Experimental Therapeutics, Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Article usage
Posted May 23, 2022.
Predictions of immunogenicity reveal potent SARS-CoV-2 CD8+ T-cell epitopes
David Gfeller, Julien Schmidt, Giancarlo Croce, Philippe Guillaume, Sara Bobisse, Raphael Genolet, Lise Queiroz, Julien Cesbron, Julien Racle, Alexandre Harari
bioRxiv 2022.05.23.492800; doi: https://doi.org/10.1101/2022.05.23.492800
Predictions of immunogenicity reveal potent SARS-CoV-2 CD8+ T-cell epitopes
David Gfeller, Julien Schmidt, Giancarlo Croce, Philippe Guillaume, Sara Bobisse, Raphael Genolet, Lise Queiroz, Julien Cesbron, Julien Racle, Alexandre Harari
bioRxiv 2022.05.23.492800; doi: https://doi.org/10.1101/2022.05.23.492800
Subject Area
Subject Areas
- Biochemistry (11730)
- Bioengineering (8743)
- Bioinformatics (29179)
- Biophysics (14964)
- Cancer Biology (12080)
- Cell Biology (17399)
- Clinical Trials (138)
- Developmental Biology (9417)
- Ecology (14174)
- Epidemiology (2067)
- Evolutionary Biology (18294)
- Genetics (12233)
- Genomics (16791)
- Immunology (11858)
- Microbiology (28051)
- Molecular Biology (11575)
- Neuroscience (60919)
- Paleontology (451)
- Pathology (1870)
- Pharmacology and Toxicology (3238)
- Physiology (4955)
- Plant Biology (10422)
- Synthetic Biology (2881)
- Systems Biology (7338)
- Zoology (1650)